Area of research
Biomedical Engineering · Molecular Biology
Research interest
Research focused on Cancer research and microRNA, with related work in Autophagy, Nanotechnology, Microvesicles. Notable publications include 'Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant', 'Tuning the autophagy-inducing activity of lanthanide-based nanocrystals through specific surface-coating peptides', and 'Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1'.
Metal‐based smart nanosystems in cancer immunotherapy
Corrigendum to: [Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells]
Recent advances in single-atom nanozymes for colorimetric biosensing
1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis
Design, synthesis and pharmacological characterization of aminopyrimidine derivatives as BTK/FLT3 dual-target inhibitors against acute myeloid leukemia
TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity
Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination Chemotherapy
A “Double-Locked” and Enzyme/pH-Activated Theranostic Agent for Accurate Tumor Imaging and Therapy
EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer
A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma
Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1
High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
The incidence, risk factors and characteristics of pressure ulcers in hospitalized patients in China.
PubMed 2014cited by 104position: middle
Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease
Associations between serum hepcidin, ferritin and Hb concentrations and type 2 diabetes risks in a Han Chinese population
Tuning the autophagy-inducing activity of lanthanide-based nanocrystals through specific surface-coating peptides